Global Wealth Management Investment Advisory’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,499
Closed -$1.37M 149
2024
Q3
$1.37M Buy
11,499
+441
+4% +$58.8K 0.3% 85
2024
Q2
$1.58M Buy
11,058
+374
+4% +$49.6K 0.37% 73
2024
Q1
$1.37M Buy
10,684
+10,268
+2,468% +$1.22M 0.34% 79
2023
Q4
$43K Buy
416
+6
+1% +$593 0.01% 201
2023
Q3
$37.3K Hold
410
0.01% 209
2023
Q2
$33.2K Buy
+410
New +$33.5K 0.01% 217
2022
Q3
Sell
-410
Closed -$23K 357
2022
Q2
$23K Hold
410
0.01% 230
2022
Q1
$23K Hold
410
0.01% 248
2021
Q4
$23K Hold
410
0.01% 246
2021
Q3
$20K Hold
410
0.01% 261
2021
Q2
$17K Hold
410
0.01% 258
2021
Q1
$14K Hold
410
0.01% 281
2020
Q4
$14K Hold
410
0.01% 255
2020
Q3
$14K Hold
410
0.01% 253
2020
Q2
$13K Hold
410
0.01% 322
2020
Q1
$12K Hold
410
0.01% 309
2019
Q4
$12K Hold
410
0.01% 333
2019
Q3
$11K Hold
410
0.01% 315
2019
Q2
$10K Hold
410
﹤0.01% 369
2019
Q1
$11K Sell
410
-372
-48% -$9.14K 0.01% 369
2018
Q4
$18K Buy
+782
New +$17.4K 0.01% 311

Other funds holding NVO

Global Wealth Management Investment Advisory's NVO Position: Q4 2024 in Review

Global Wealth Management Investment Advisory sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 11,499 shares — an estimated $1.37M sold.

Global Wealth Management Investment Advisory first reported a position in NVO in Q4 2018 and held it in 21 quarters. The position peaked at $1.58M in Q2 2024. 1,664 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Global Wealth Management Investment Advisory reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 11,499 Novo Nordisk shares in Q4 2024, an estimated $1.37M.
  • Global Wealth Management Investment Advisory first reported a position in Novo Nordisk in Q4 2018 and held it in 21 quarters.
  • Global Wealth Management Investment Advisory's Novo Nordisk position peaked at $1.58M in Q2 2024.
  • 1,664 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Global Wealth Management Investment Advisory's 13F filing for Q4 2024, filed 29 Jan 2025.